InvestSMART

Identifai Genetics Limited (ASX: ID1) - Share Price

- Current share price for ID1 : $0.420

Identifai Genetics Limited's (ID1) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It main activities of the Company, Identifai Genetics Limited (Identifai Israel) and Identifai Genetics Inc. (Identifai US) (collectively, the Group) are operated through Identifai Israel.

ID1 General Information +

ASX Code ID1
Website http://www.identifai-genetics.com
Industry/Sector Life Sciences Tools & Services
Market Cap ($M) 45
ID1 Share Price $0.420
Day High $0.430
Day Low $0.420
Last Close $0.420
ID1 Share Price Movement - ( No change )
Prices as at 16:40, 13 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Identifai Genetics Limited (ID1) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Identifai Genetics Limited (ID1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Identifai Genetics Limited (ID1) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 Becoming a substantial holder 19 Oct 2026 5:01PM $0.430 $0.420 fallen by 2.33%
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 Becoming a substantial holder 16 Oct 2026 2:31PM $0.385 $0.420 risen by 9.09%
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 IPO Investor Presentation 14 Oct 2026 12:27PM $0.320 $0.420 risen by 31.25%
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 Becoming a substantial holder 13 Oct 2026 4:55PM $0.250 $0.420 risen by 68%
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 Initial Director's Interest Notice x 4 13 Oct 2026 4:15PM $0.250 $0.420 risen by 68%
Identifai Genetics Limited (ID1)
ORDINARY FULLY PAID
 Health Care $46 Interim Report 13 Oct 2026 1:10PM $0.235 $0.420 risen by 78.72%

ID1 Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
Identifai Genetics Limited (ID1) $46M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

ID1 Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.00 0.00
Market 0.31 13.30 1.04 0.78
Sector 0.79 32.20 2.27 2.79

ID1 Directors

Name Position Start Date
Mr Yoseph Bornstein Non-Executive Chairman, Non-Executive Director 12 Jun 2026
Mr Ata Gokyildirim Non-Executive Director 18 Feb 2026
Ms Lucy Robb Vujcic Non-Executive Director 24 Mar 2026
Mr Kobi Caspi Non-Executive Director 13 Jul 2026

Identifai Genetics Limited (ID1) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value

See all changes in directors' interest & trades for Identifai Genetics Limited (ID1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ID1 Management

Name Position
Eyal Miller Chief Executive Officer
Sebastian Henryk Andre Company Secretary

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.